Revenue
1.11 million USD
2027 Q1 · USD
Exact inputs and evidence
- Revenue: 1109661 USD Source
Annual consolidated revenue for 2026: about USD 3.711M, using the latest reported figures. The previous period, 2025, was about USD 9.011M.
1.11 million USD
2027 Q1 · USD
-164.72%
2027 Q1 · %
-2.22 million USD
2027 Q1 · USD
646009 USD
1600000 USD
121710366 shares
12.06% · 13.1 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
5.49 million USD
2022-07-01 – 2023-06-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-12.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 9.01 million
–
Current period
USD 3.71 million
–
3710714 − 9011081 = -5300367 USD
9011081 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source3710714 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 9.8 million
–
Current period
USD 19.17 million
–
19167678 − -9798083 = 28965761 USD
-9798083 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source19167678 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 1.59 million
–
Current period
USD 123,028
–
123028 − -1591426 = 1714454 USD
-1591426 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source123028 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2022-01-01 – 2022-12-31 | 4832278 | 5932711 Derived | -1100433 | -28257 Derived | -1072176 | -6416835 Derived | Source
|
| 2024 2023-01-01 – 2023-12-31 | 19346306 | 17133053 Derived | 2213253 | -917802 Derived | 3131055 | Unavailable | Source
|
| 2025 2024-01-01 – 2024-12-31 | 9011081 | 11163619 Derived | -2152538 | 7645545 Derived | -9798083 | Unavailable | Source
|
| 2026 2025-01-01 – 2025-12-31 | 3710714 | 5450578 Derived | -1739864 | -20907542 Derived | 19167678 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 4832278 |
|
| 2024 | Revenue | 19346306 |
|
| 2025 | Revenue | 9011081 |
|
| 2026 | Revenue | 3710714 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 300.4% |
|
| 2025 | Year over year | -53.4% |
|
| 2026 | Year over year | -58.8% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -22.8% |
|
| 2024 | Operating margin | 11.4% |
|
| 2025 | Operating margin | -23.9% |
|
| 2026 | Operating margin | -46.9% |
|
| 2023 | Net margin | -22.2% |
|
| 2024 | Net margin | 16.2% |
|
| 2025 | Net margin | -108.7% |
|
| 2026 | Net margin | 516.5% |
|
| 2023 | Free cash flow margin | -132.8% |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
| 2026 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -603778 |
|
| 2024 | Operating cash flow | 438637 |
|
| 2025 | Operating cash flow | -1591426 |
|
| 2026 | Operating cash flow | 123028 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -6416835 |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
| 2026 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 64.3% |
|
| 2024 | Liabilities / assets | 59.8% |
|
| 2025 | Liabilities / assets | 86.5% |
|
| 2026 | Liabilities / assets | 69.3% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 0.92× |
|
| 2024 | Current assets / current liabilities | 1.08× |
|
| 2025 | Current assets / current liabilities | 1.21× |
|
| 2026 | Current assets / current liabilities | 0.74× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2019-04-01 – 2020-03-31 | −USD 4.37 million Exact valueExact value: -4365355 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.59 million Exact valueExact value: -3590516 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-04-01 – 2021-03-31 | −USD 880,851 Exact valueExact value: -880851 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.61 million Exact valueExact value: -1605076 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-01-01 – 2022-12-31 | −USD 1.07 million Exact valueExact value: -1072176 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 603,778 Exact valueExact value: -603778 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5.81 million Exact valueExact value: 5813057 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 6.42 million Calculation and evidence-603778 − 5813057 USD Exact free cash flow: -6416835 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-01-01 – 2023-12-31 | USD 3.13 million Exact valueExact value: 3131055 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 438,637 Exact valueExact value: 438637 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2024-01-01 – 2024-12-31 | −USD 9.8 million Exact valueExact value: -9798083 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.59 million Exact valueExact value: -1591426 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2026 2025-01-01 – 2025-12-31 | USD 19.17 million Exact valueExact value: 19167678 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 123,028 Exact valueExact value: 123028 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
90 filings · 4,251 latest values · 4,251 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001438943, 1438943, MLCT, RNGE, STVF, STVFD, VBIO, edgar:1438943, stvf
Also known as Legend Mining Inc., MALACHITE INNOVATIONS, INC., RANGE IMPACT, INC., Stevia First Corp., VITALITY BIOPHARMA, INC., Vitality Biopharma, Inc.